Immuron - ADR (IMRN) Peer Comparison

$1.14

$0.00 (0.00%)

As on 26-Aug-2026 16:00EDT

Market cap

$9 Mln

Revenue (TTM)

$11 Mln

P/E Ratio

--

P/B Ratio

1

Div. Yield

0 %

Edit

	Immuron - ADR (IMRN)	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR
Market cap ($ Mln)	9	153	85
Revenue (A$ Mln)	7	0	5
Net Profit (A$ Mln)	-5.22	-20.70	-12.15
Net Margin (%)	-71.92	-2,284,277.09	-531.34
RoE (%)	-50.30	226.03	-43.23
Price to Earnings	--	--	--
Price-To-Book	1.03	4.63	2.19

Income Statement
Liabilities
Assets
Cashflow
Ratios

Income Statement (A$ Mln)

	Immuron - ADR (IMRN)	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR
Operating Revenue	7.29	0.04	5.44
Cost of Revenue	2.52	--	0.13
Gross Profit	4.77	0.04	5.31
Operating Expenses	10.11	14.26	19.89
Operating Profit (EBIT)	-5.34	-14.22	-14.57
Other Income	--	--	--
Profit before Tax	-5.22	-22.45	-12.08
Provision for Tax	--	-1.75	0.07
Profit after Tax (Net Income)	-5.22	-20.70	-12.15
Minority Interest	--	--	--
Consolidated Profit	--	--	--

Liabilities (A$ Mln)

	Immuron - ADR (IMRN)	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR
Shareholder's Funds	8.03	-8.30	42.40
Minority Interest	--	--	--
Non-Current Liabilities	0.09	0.31	0.09
Current Liabilities	1.97	14.05	3.53
Total Liabilities	10.09	6.06	46.03

Assets (A$ Mln)

	Immuron - ADR (IMRN)	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR
Non-Current Assets	0.11	1.13	0.16
Current Assets	9.98	4.93	45.87
Total Assets	10.09	6.06	46.03
Total Debt*	0.12	0.40	0.16
Net Current Assets	8.05	-9.12	42.34

Cashflow (A$ Mln)

	Immuron - ADR (IMRN)	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR
Cash From Operating Activities	-6.14	-13.28	-11.45
Cash Flow from Investing Activities	-2.90	--	-7.50
Cash from Financing Activities	0.20	15.98	39.67
Net Cash Inflow / Outflow	--	--	--

Ratios

Profitability Ratios

	Immuron - ADR (IMRN)	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR
ROCE (%)	-49.60	239.50	-42.99
ROE (%)	-50.30	226.03	-43.23
ROA (%)	-40.68	-149.76	-37.23
EBIT Margin (%)	--	--	--
Net Margin (%)	-71.58	-49,290.48	-223.35
Cash Profit Margin (%)	--	--	--

Growth Ratios

	Immuron - ADR (IMRN)	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR
Revenue Growth (%)	0.49	-0.98	0.35
EBIT Growth (%)	--	--	--
Net Profit Growth (%)	24.81	22.69	36.48
EPS Growth (%)	0.27	0.56	0.46
Book Value Growth (%)	--	--	--

Valuation Ratios

	Immuron - ADR (IMRN)	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR
Price / Earnings	-1.95	-0.26	-4.20
Price / Book Value	1.27	-0.64	1.20
Dividend Yield (%)	--	--	--
EV/EBITDA	-0.84	-0.10	-0.72
Market Cap ($ Cr)	--	--	--

Solvency Ratios

	Immuron - ADR (IMRN)	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR
Debt to Equity	0.01	-0.05	0.00
Short term debt to equity ratio	0.01	-0.05	0.00
Current Ratio	5.07	0.35	12.98
Quick Ratio	4.17	--	--
Interest Coverage	-733.30	--	--

Operating Efficiency Ratios

	Immuron - ADR (IMRN)	Kazia Therapeutics - ADR	Alterity Therapeutics - ADR
Debtors to sales (%)	10.86	214.29	72.40
Asset Turnover	0.57	0.00	0.17
Receivable days	54.61	969.65	267.92
Inventory Days	243.10	--	-64.13
Payable days	157.74	--	1,603.11
Cash Conversion Cycle	139.96	--	-1,399.31

Annual
Quarterly